Infliximab in pediatric Crohn's disease: Long-tenn follow-up of an unselected cohort

被引:0
|
作者
Ridder, Lissy D.
Rings, Edmond
Benninga, Marc A.
Taminiau, Jan
Kneepkens, Frank
Escher, Johanna
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A182 / A182
页数:1
相关论文
共 50 条
  • [1] Infliximab dependency in pediatric Crohn's disease: Long-term follow-up of an unselected cohort
    de Ridder, Lissy
    Rings, Edmond H. H. M.
    Damen, Gerard M.
    Kneepkens, C. M. Frank
    Schweizer, Joachim J.
    Kokke, Freddy T. M.
    Benninga, Marc A.
    Norbruis, Obbe F.
    Hoekstra, J. Hans
    Gijsbers, Carolien F. M.
    Escher, Johanna C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 353 - 358
  • [2] Infliximab in paediatric Crohn's disease: Long-term follow-up of an unselected cohort
    De Ridder, L.
    Rings, E. H.
    Benninga, M. A.
    Taminiau, J. A.
    Kneepkens, C. M. F.
    Escher, J. C.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 : 102 - 102
  • [3] Infliximab in paediatric Crohn's disease: long-term follow-up of an unselected cohort
    de Ridder, L.
    Rings, E. H.
    Benninga, M. A.
    Taminiau, J. A.
    Kneepkens, C. M. F.
    Escher, J. C.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A2 - A3
  • [4] Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up
    Lee, Yun Seok
    Baek, Sang Hun
    Kim, Mi Jin
    Lee, Yoo Min
    Lee, Yoon
    Choe, Yon Ho
    [J]. PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2012, 15 (04) : 243 - 249
  • [5] Maintenance of Clinical Benefit in Crohn's Disease Patients After Discontinuation of Infliximab: Long Term Follow-up of a Single Center Cohort
    Waugh, Alistair W.
    Wong, Karen
    Fedorak, Richard N.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S685 - S685
  • [6] 12-month follow-up after successful infliximab therapy in pediatric Crohn disease
    Wynands, Jan
    Belbouab, Reda
    Candon, Sophie
    Talbotec, Cecile
    Mougenot, Jean-Francois
    Chatenoud, Lucienne
    Schmitz, Jacques
    Cezard, Jean-Pierre
    Goulet, Oliver
    Hugot, Jean-Pierre
    Ruemmele, Frank M.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 46 (03): : 293 - 298
  • [7] Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up
    Wenzl, HH
    Reinisch, W
    Jahnel, J
    Stockenhuber, F
    Tilg, H
    Kirchgatterer, A
    Petritsch, W
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (08) : 767 - 773
  • [8] Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
    Waugh, A. W. G.
    Garg, S.
    Matic, K.
    Gramlich, L.
    Wong, C.
    Sadowski, D. C.
    Millan, M.
    Bailey, R.
    Todoruk, D.
    Cherry, R.
    Teshima, C. W.
    Dieleman, L.
    Fedorak, R. N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (09) : 1129 - 1134
  • [9] Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
    Sorrentino, Dario
    Hauenstein, Scott
    Marino, Marco
    Lockton, Steven
    Zarifi, Dimitra
    Del Bianco, Tiziana
    Singh, Sharat
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S777 - S777
  • [10] Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
    Sorrentino, Dario
    Marino, Marco
    Dassopoulos, Themistocles
    Zarifi, Dimitra
    Del Bianco, Tiziana
    [J]. PLOS ONE, 2015, 10 (12):